Skip to main content

Table 1 Common indications for rituximab therapy

From: Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective

Disease conditions

Chronic lymphocytic leukemia

CD20+ non-Hodgkin lymphoma (expressing the B-lymphocyte antigen CD20)

Rheumatoid arthritis

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis

   • Granulomatosis with polyangiitis (formerly Wegener's granulomatosis)

   • Microscopic polyangiitis

   • Eosinophilic granulomatosis associated with polyangiitis (formerly Churg-Strauss syndrome) (unlabeled)

Chronic refractory graft-versus-host disease (unlabeled)

Refractory idiopathic thrombocytopenic purpura (unlabeled)

Hodgkin lymphoma (unlabeled)

Refractory pemphigus vulgaris (unlabeled)

Post-transplant lymphoproliferative disorder (unlabeled)

Waldenström macroglobulinemia (unlabeled)

Type I diabetes mellitus (unlabeled)

Multiple sclerosis (unlabeled)

Renal transplant (unlabeled)